Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Revenue by Segment

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017	May 31, 2016
Pharmaceuticals Business	50.64B	46.90B	45.10B	43.46B	48.71B
Pharmaceuticals Business Growth	7.99%	3.98%	3.77%	-10.78%	8.27%
Total	50.64B	46.90B	45.10B	43.46B	48.71B
Total Growth	7.99%	3.98%	3.77%	-10.78%	8.27%

Revenue by Geography

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017	May 31, 2016
Japan	50.64B	46.90B	45.10B	43.46B	48.71B
Japan Growth	7.99%	3.98%	3.77%	-10.78%	8.27%
Total	50.64B	46.90B	45.10B	43.46B	48.71B
Total Growth	7.99%	3.98%	3.77%	-10.78%	8.27%

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error